Evidence map›Paper›PMID 31034354›Full record

ArticleMolecular biology of the cell2019

Human organoids: a new dimension in cell biology.

Ruth Lehmann, Connie M Lee, Erika C Shugart, Marta Benedetti, R Alta Charo, Zev Gartner, Brigid Hogan, Jürgen Knoblich, Celeste M Nelson, Kevin M Wilson

Abstract readEditorial
In one paragraph

Article in Molecular biology of the cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Frontiers in immunology · 2021
    Pooled it
  2. Article
  3. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
  4. CRISPR/Cas9-based nanodelivery systems for precision gene editing in neuroinflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  5. Review
  6. Recent advancements and limitations of intestinal organoids for clinical applications.Progress in biomedical engineering (Bristol, England) · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Hepatoprotective Potential of Indian Medicinal Plants.Combinatorial chemistry & high throughput screening · 2026
    Review
  13. Review
  14. Review
  15. Gastrointestinal tract, its pathophysiology andWorld journal of gastroenterology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruth LehmannHHMI and Skirball Institute of Biomolecular Medicine, Department of Cell Biology, NYU School of Medicine, New York, NY 10016.
Connie M LeeBiological Sciences Division, University of Chicago, Chicago IL 60637.
Erika C ShugartThe American Society for Cell Biology, Bethesda, MD 20814.
Marta BenedettiSimons Foundation, New York, NY 10010.
R Alta CharoUniversity of Wisconsin Madison Law School, Madison, WI 53706.
Zev GartnerDepartment of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, San Francisco, CA 94158.
Brigid HoganDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710.
Jürgen KnoblichInstitute of Molecular Biotechnology, Austrian Academy of Sciences, 1030 Vienna, Austria.
Celeste M NelsonDepartment of Chemical and Biological Engineering and Department of Molecular Biology, Princeton University, Princeton, NJ 08544.
Kevin M WilsonThe American Society for Cell Biology, Bethesda, MD 20814.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organoids derived from stem cells or tissues in culture can develop into structures that resemble the in vivo anatomy and physiology of intact organs. Human organoid cultures provide the potential to study human development and model disease processes with the same scrutiny and depth of analysis customary for research with nonhuman model organisms. Resembling the complexity of the actual tissue or organ, patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine, generating knowledge and tools for preclinical studies, including drug development and testing. Biologists are drawn to this system as a new "model organism" to study complex disease phenotypes and genetic variability among individuals using patient-derived tissues. The American Society for Cell Biology convened a task force to report on the potential, challenges, and limitations for human organoid research. The task force suggests ways to ease the entry for new researchers into the field and how to facilitate broader use of this new model organism within the research community. This includes guidelines for reproducibility, culturing, sharing of patient materials, patient consent, training, and communication with the public.

Indexed as

OrganoidsAnimalsBiomedical ResearchCell Culture TechniquesGuidelines as TopicHumansModels, BiologicalRegenerative MedicineReproducibility of ResultsStem CellsTissue Engineering

Identifiers

PMID31034354
PMCPMC6724519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.